Xie Y, Shi X, Sheng K, Han G, Li W, Zhao Q
Mol Med Rep. 2018; 19(2):783-791.
PMID: 30535469
PMC: 6323245.
DOI: 10.3892/mmr.2018.9713.
Bock S, Mullins C, Klar E, Perot P, Maletzki C, Linnebacher M
Front Microbiol. 2018; 9:789.
PMID: 29755432
PMC: 5932414.
DOI: 10.3389/fmicb.2018.00789.
Kawasaki J, Kawamura M, Ohsato Y, Ito J, Nishigaki K
J Virol. 2017; 91(20).
PMID: 28768854
PMC: 5625498.
DOI: 10.1128/JVI.00829-17.
Peloponese Jr J, Yeung M, Jeang K
Immunol Res. 2016; 34(1):1-12.
PMID: 27519575
DOI: 10.1385/IR:34:1:1.
Nozhat Z, Hedayati M
Mol Diagn Ther. 2015; 20(1):13-26.
PMID: 26597586
DOI: 10.1007/s40291-015-0175-y.
Phosphoinositides: Key modulators of energy metabolism.
Bridges D, Saltiel A
Biochim Biophys Acta. 2014; 1851(6):857-66.
PMID: 25463477
PMC: 4975561.
DOI: 10.1016/j.bbalip.2014.11.008.
Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastoma.
Wallace 4th G, Dixon-Mah Y, Vandergrift 3rd W, Ray S, Haar C, Mittendorf A
Metab Brain Dis. 2013; 28(3):355-66.
PMID: 23543207
PMC: 4314306.
DOI: 10.1007/s11011-013-9401-7.
Myocardial AKT: the omnipresent nexus.
Sussman M, Volkers M, Fischer K, Bailey B, Cottage C, Din S
Physiol Rev. 2011; 91(3):1023-70.
PMID: 21742795
PMC: 3674828.
DOI: 10.1152/physrev.00024.2010.
Ex vivo γ-retroviral gene therapy of dogs with X-linked severe combined immunodeficiency and the development of a thymic T cell lymphoma.
Kennedy D, Hartnett B, Kennedy J, Vernau W, Moore P, OMalley T
Vet Immunol Immunopathol. 2011; 142(1-2):36-48.
PMID: 21536334
PMC: 3109141.
DOI: 10.1016/j.vetimm.2011.04.003.
Targeting signal transduction pathways to eliminate chemotherapeutic drug resistance and cancer stem cells.
McCubrey J, Abrams S, Stadelman K, Chappell W, Lahair M, Ferland R
Adv Enzyme Regul. 2009; 50(1):285-307.
PMID: 19895837
PMC: 2862855.
DOI: 10.1016/j.advenzreg.2009.10.016.
Non-peptidic substrate-mimetic inhibitors of Akt as potential anti-cancer agents.
Kayser-Bricker K, Glenn M, Lee S, Sebti S, Cheng J, Hamilton A
Bioorg Med Chem. 2009; 17(4):1764-71.
PMID: 19179081
PMC: 4037933.
DOI: 10.1016/j.bmc.2008.09.058.
Akt2 regulation of Cdc2-like kinases (Clk/Sty), serine/arginine-rich (SR) protein phosphorylation, and insulin-induced alternative splicing of PKCbetaII messenger ribonucleic acid.
Jiang K, Patel N, Watson J, Apostolatos H, Kleiman E, Hanson O
Endocrinology. 2009; 150(5):2087-97.
PMID: 19116344
PMC: 2671910.
DOI: 10.1210/en.2008-0818.
The transforming mutation E17K/AKT1 is not a major event in B-cell-derived lymphoid leukaemias.
Mahmoud I, Sughayer M, Mohammad H, Awidi A, El-Khateeb M, Ismail S
Br J Cancer. 2008; 99(3):488-90.
PMID: 18665177
PMC: 2527790.
DOI: 10.1038/sj.bjc.6604512.
Targeting prostate cancer based on signal transduction and cell cycle pathways.
Lee J, Lehmann B, Terrian D, Chappell W, Stivala F, Libra M
Cell Cycle. 2008; 7(12):1745-62.
PMID: 18594202
PMC: 2593475.
DOI: 10.4161/cc.7.12.6166.
Inhibition of protein synthesis by Y box-binding protein 1 blocks oncogenic cell transformation.
Bader A, Vogt P
Mol Cell Biol. 2005; 25(6):2095-106.
PMID: 15743808
PMC: 1061623.
DOI: 10.1128/MCB.25.6.2095-2106.2005.
Specificity in the activation and control of transcription factor E2F-dependent apoptosis.
Hallstrom T, Nevins J
Proc Natl Acad Sci U S A. 2003; 100(19):10848-53.
PMID: 12954980
PMC: 196891.
DOI: 10.1073/pnas.1831408100.
Essential role of AKT-1/protein kinase B alpha in PTEN-controlled tumorigenesis.
Stiles B, Gilman V, Khanzenzon N, Lesche R, Li A, Qiao R
Mol Cell Biol. 2002; 22(11):3842-51.
PMID: 11997518
PMC: 133830.
DOI: 10.1128/MCB.22.11.3842-3851.2002.
Mechanisms of transformation by the BCR/ABL oncogene.
Sattler M, Griffin J
Int J Hematol. 2001; 73(3):278-91.
PMID: 11345193
DOI: 10.1007/BF02981952.
Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway.
Swart R, Ruf I, Sample J, Longnecker R
J Virol. 2000; 74(22):10838-45.
PMID: 11044134
PMC: 110964.
DOI: 10.1128/jvi.74.22.10838-10845.2000.
Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo.
Jones R, Parsons M, Bonnard M, Chan V, Yeh W, Woodgett J
J Exp Med. 2000; 191(10):1721-34.
PMID: 10811865
PMC: 2193154.
DOI: 10.1084/jem.191.10.1721.